Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 358

1.

Radical radiotherapy for locally advanced non-small cell lung cancer-what's up with arm positioning?

Murrell DH, Karnas SJ, Corkum MT, Hipwell S, Palma DA, Rodrigues G, Louie AV.

J Thorac Dis. 2019 May;11(5):2099-2104. doi: 10.21037/jtd.2019.05.40.

PMID:
31285903
Free PMC Article
2.

Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceous.

Yang A, Xuan R, Melbourne W, Tran K, Murrell DF.

J Eur Acad Dermatol Venereol. 2019 Jul 1. doi: 10.1111/jdv.15770. [Epub ahead of print]

PMID:
31260565
3.

Pemphigus vulgaris accompanied with amyotrophic lateral sclerosis: a rare coincidence or pathogenic relationship?

Bilgic A, Murrell DF.

Eur J Dermatol. 2019 Jun 27. doi: 10.1684/ejd.2019.3577. [Epub ahead of print] No abstract available.

PMID:
31251210
4.

Pemphigus vulgaris disease activity: The role of antibodies to desmogleins and their isotype.

Yeoh SC, Byth-Wilson K, Murrell DF, Schifter M, Lin MW, Fulcher DA.

J Oral Pathol Med. 2019 Jun 13. doi: 10.1111/jop.12913. [Epub ahead of print]

PMID:
31192484
5.

Pathogenesis and clinical features of alopecia in epidermolysis bullosa: A systematic review.

Xie D, Bilgic-Temel A, Abu Alrub N, Murrell DF.

Pediatr Dermatol. 2019 Jul;36(4):430-436. doi: 10.1111/pde.13866. Epub 2019 Jun 9. Review.

PMID:
31177584
6.

Review of autoimmune blistering diseases: the Pemphigoid diseases.

Daniel BS, Murrell DF.

J Eur Acad Dermatol Venereol. 2019 May 13. doi: 10.1111/jdv.15679. [Epub ahead of print] Review.

PMID:
31087464
7.

When do we have the power to detect biological interactions in spatial point patterns?

Rajala T, Olhede SC, Murrell DJ.

J Ecol. 2019 Mar;107(2):711-721. doi: 10.1111/1365-2745.13080. Epub 2018 Oct 23.

8.

Editorial: Skin Blistering Diseases.

Has C, Amber KT, Murrell DF, Musette P, Ludwig RJ.

Front Med (Lausanne). 2019 Apr 2;6:60. doi: 10.3389/fmed.2019.00060. eCollection 2019. No abstract available.

9.

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.

Sekulic A, Migden MR, Basset-Seguin N, Garbe C, Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, Quevedo JF, Hou J, McKenna E, Dimier N, Williams S, Schadendorf D, Hauschild A; ERIVANCE BCC Investigators.

BMC Cancer. 2019 Apr 18;19(1):366. doi: 10.1186/s12885-019-5568-6.

10.

Pharmacological advances in pemphigus.

Bilgic Temel A, Murrell DF.

Curr Opin Pharmacol. 2019 Apr 8;46:44-49. doi: 10.1016/j.coph.2019.01.001. [Epub ahead of print] Review.

PMID:
30974409
11.

A new indirect immunofluorescence BIOCHIP method for the serological diagnosis of bullous pemphigoid: A review of literature.

Yang A, Xuan R, Murrell DF.

Australas J Dermatol. 2019 Apr 9. doi: 10.1111/ajd.13034. [Epub ahead of print] Review.

PMID:
30968398
12.

Patients left behind: Rare dermatologic conditions miss the orphan drug development boom.

Chavez A, Licholai G, Murrell DF.

J Am Acad Dermatol. 2019 Mar 14. pii: S0190-9622(19)30427-X. doi: 10.1016/j.jaad.2019.03.013. [Epub ahead of print]

PMID:
30880063
14.

Diagnostic Criteria and Phenotypes of Pemphigoid and the Association With Gliptins.

Temel AB, Murrell DF.

JAMA Dermatol. 2019 Feb 1;155(2):147-148. doi: 10.1001/jamadermatol.2018.4847. No abstract available.

PMID:
30624564
15.

HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study.

Murrell DE, Cluck DB, Moorman JP, Brown SD, Wang KS, Duffourc MM, Harirforoosh S.

Clin Drug Investig. 2019 Mar;39(3):285-299. doi: 10.1007/s40261-018-0739-9.

PMID:
30623371
16.

Probiotics for treating eczema.

Makrgeorgou A, Leonardi-Bee J, Bath-Hextall FJ, Murrell DF, Tang ML, Roberts A, Boyle RJ.

Cochrane Database Syst Rev. 2018 Nov 21;11:CD006135. doi: 10.1002/14651858.CD006135.pub3.

PMID:
30480774
17.

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference.

Lee J, Werth VP, Hall RP 3rd, Eming R, Fairley JA, Fajgenbaum DC, Harman KE, Jonkman MF, Korman NJ, Ludwig RJ, Murrell DF, Musette P, Naik HB, Sadik CD, Yamagami J, Yale ML, Payne AS.

Front Med (Lausanne). 2018 Nov 8;5:306. doi: 10.3389/fmed.2018.00306. eCollection 2018.

18.

Is the Oral Disease Severity Score going to be useful for dermatologists when assessing pemphigus?

Murrell DF, Caux F, Prost-Squarcioni C.

Br J Dermatol. 2018 Oct;179(4):816-817. doi: 10.1111/bjd.16911. No abstract available.

PMID:
30318808
19.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology.

J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. Review.

PMID:
30301637
20.

Identifying Opportunities to Provide Family-centered Care for Families With Children With Type 1 Spinal Muscular Atrophy.

Murrell DV, Crawford CA, Jackson CT, Lotze TE, Wiemann CM.

J Pediatr Nurs. 2018 Nov - Dec;43:111-119. doi: 10.1016/j.pedn.2018.09.007. Epub 2018 Sep 25.

PMID:
30266528
21.

Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab.

de Brito M, Huebner G, Murrell D, Bullpitt P, Hartmann K.

Clin Transl Allergy. 2018 Sep 21;8:37. doi: 10.1186/s13601-018-0222-y. eCollection 2018.

22.

Epidermolysis Bullosa Patients' Perception of Surgical Wound and Scar Healing.

Harris AG, Saikal SL, Murrell DF.

Dermatol Surg. 2019 Feb;45(2):280-289. doi: 10.1097/DSS.0000000000001673.

PMID:
30204740
23.

Pemphigoid gestationis and intravenous immunoglobulin therapy.

Yang A, Uhlenhake E, Murrell DF.

Int J Womens Dermatol. 2018 May 3;4(3):166-169. doi: 10.1016/j.ijwd.2018.03.007. eCollection 2018 Sep.

24.

The effects of autoimmune blistering diseases on work productivity: A review.

Wang EQ, Castrillón Velásquez MA, Murrell DF.

Int J Womens Dermatol. 2018 Feb 9;4(3):131-138. doi: 10.1016/j.ijwd.2017.11.001. eCollection 2018 Sep. Review.

25.

Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies.

Phan K, Goyal S, Murrell DF.

Australas J Dermatol. 2019 Feb;60(1):23-28. doi: 10.1111/ajd.12899. Epub 2018 Aug 23.

PMID:
30141189
26.

APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

Cho RJ, Alexandrov LB, den Breems NY, Atanasova VS, Farshchian M, Purdom E, Nguyen TN, Coarfa C, Rajapakshe K, Prisco M, Sahu J, Tassone P, Greenawalt EJ, Collisson EA, Wu W, Yao H, Su X, Guttmann-Gruber C, Hofbauer JP, Hashmi R, Fuentes I, Benz SC, Golovato J, Ehli EA, Davis CM, Davies GE, Covington KR, Murrell DF, Salas-Alanis JC, Palisson F, Bruckner AL, Robinson W, Has C, Bruckner-Tuderman L, Titeux M, Jonkman MF, Rashidghamat E, Lwin SM, Mellerio JE, McGrath JA, Bauer JW, Hovnanian A, Tsai KY, South AP.

Sci Transl Med. 2018 Aug 22;10(455). pii: eaas9668. doi: 10.1126/scitranslmed.aas9668.

PMID:
30135250
27.

NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.

Ramos J, Das J, Felty Q, Yoo C, Poppiti R, Murrell D, Foster PJ, Roy D.

Breast Cancer Res Treat. 2018 Nov;172(2):469-485. doi: 10.1007/s10549-018-4905-9. Epub 2018 Aug 20.

PMID:
30128822
28.

Prevalence and pathogenesis of osteopenia and osteoporosis in epidermolysis bullosa: An evidence-based review.

Chen JS, Yang A, Murrell DF.

Exp Dermatol. 2018 Aug 17. doi: 10.1111/exd.13771. [Epub ahead of print] Review.

PMID:
30118182
29.

New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature.

Xuan RR, Yang A, Murrell DF.

Int J Womens Dermatol. 2018 Feb 3;4(2):102-108. doi: 10.1016/j.ijwd.2017.10.001. eCollection 2018 Jun. Review.

30.

Psychosocial impact of inherited and autoimmune blistering diseases.

Jain SV, Murrell DF.

Int J Womens Dermatol. 2018 Jan 8;4(1):49-53. doi: 10.1016/j.ijwd.2017.11.004. eCollection 2018 Mar. Review.

31.

Half brain irradiation in a murine model of breast cancer brain metastasis: magnetic resonance imaging and histological assessments of dose-response.

Zarghami N, Murrell DH, Jensen MD, Dick FA, Chambers AF, Foster PJ, Wong E.

Radiat Oncol. 2018 Jun 1;13(1):104. doi: 10.1186/s13014-018-1028-8.

32.

A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases.

Lee BWH, Tan JCK, Radjenovic M, Coroneo MT, Murrell DF.

Orphanet J Rare Dis. 2018 May 22;13(1):83. doi: 10.1186/s13023-018-0823-5. Review.

33.

Image-guided radiation therapy for post-operative gynaecologic cancer: patient set up verification with and without implanted fiducial markers.

Murrell DH, Warner A, Benwell Q, Wells W, Scott D, Velker V, Hajdok G, D'Souza DP.

Acta Oncol. 2018 Oct;57(10):1346-1351. doi: 10.1080/0284186X.2018.1473638. Epub 2018 May 18.

PMID:
29774779
34.

The effect of autoimmune blistering diseases on work productivity.

Wang EQ, Radjenovic M, Castrillón MA, Feng GHY, Murrell DF.

J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1959-1966. doi: 10.1111/jdv.15062. Epub 2018 May 29.

PMID:
29730897
35.

Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?

Murrell DH, Laba JM, Erickson A, Millman B, Palma DA, Louie AV.

Radiat Oncol. 2018 Apr 2;13(1):57. doi: 10.1186/s13014-018-1001-6.

36.

Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts.

Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakaş A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM Jr, Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP.

J Am Acad Dermatol. 2018 Feb 10. pii: S0190-9622(18)30207-X. doi: 10.1016/j.jaad.2018.02.021. [Epub ahead of print]

37.

Disease-specific health related quality of life patient reported outcome measures in Genodermatoses: a systematic review and critical evaluation.

Frew JW, Davidson M, Murrell DF.

Orphanet J Rare Dis. 2017 Dec 29;12(1):189. doi: 10.1186/s13023-017-0739-5. Review.

38.

Chromatographic methods in HIV medicine: Application to therapeutic drug monitoring.

Archibald TL, Murrell DE, Brown SD.

Biomed Chromatogr. 2018 Feb;32(2). doi: 10.1002/bmc.4170. Review.

PMID:
29240228
39.

A study of the number of female editors-in-chief of dermatology journals.

Gollins CE, Shipman AR, Murrell DF.

Int J Womens Dermatol. 2017 Jun 3;3(4):185-188. doi: 10.1016/j.ijwd.2017.03.001. eCollection 2017 Dec.

40.

Rituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus.

Murrell DF, Sprecher E.

Br J Dermatol. 2017 Nov;177(5):1143-1144. doi: 10.1111/bjd.15947. No abstract available.

PMID:
29192985
41.

An Atypical Localized Form of Hidradenitis Suppurativa of the Jawline and Neck Mimicking Severe Cystic Acne on Presentation.

Castrillón Velásquez MA, Kim M, Tan MH, Tran K, Murrell DF.

Skin Appendage Disord. 2017 Oct;3(4):215-218. doi: 10.1159/000477412. Epub 2017 Jun 14.

42.

Highly Resistant Acrodermatitis Continua of Hallopeau and Pustular Psoriasis.

Frew JW, Murrell DF.

Skin Appendage Disord. 2017 Oct;3(4):179-181. doi: 10.1159/000464140. Epub 2017 Apr 29. No abstract available.

43.

International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita.

Prost-Squarcioni C, Caux F, Schmidt E, Jonkman MF, Vassileva S, Kim SC, Iranzo P, Daneshpazhooh M, Terra J, Bauer J, Fairley J, Hall R, Hertl M, Lehman JS, Marinovic B, Patsatsi A, Zillikens D; International Bullous Diseases Group, Werth V, Woodley DT, Murrell DF.

Br J Dermatol. 2018 Jul;179(1):30-41. doi: 10.1111/bjd.16138. Epub 2018 May 8. Review.

PMID:
29165796
44.

[New developments in the management of congenital epidermolysis bullosa].

Murrell D.

Ann Dermatol Venereol. 2017 Dec;144(12S):S6-S7. doi: 10.1016/j.annder.2017.09.587. Epub 2017 Oct 31. French. No abstract available.

PMID:
29096942
45.

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.

Drucker AM, Eyerich K, de Bruin-Weller MS, Thyssen JP, Spuls PI, Irvine AD, Girolomoni G, Dhar S, Flohr C, Murrell DF, Paller AS, Guttman-Yassky E.

Br J Dermatol. 2018 Mar;178(3):768-775. doi: 10.1111/bjd.15928. Epub 2018 Jan 28.

46.

Epidemiology and Outcome of Squamous Cell Carcinoma in Epidermolysis Bullosa in Australia and New Zealand.

Kim M, Li M, Intong-Wheeler LRA, Tran K, Marucci D, Murrell DF.

Acta Derm Venereol. 2018 Jan 12;98(1):70-76. doi: 10.2340/00015555-2781.

47.

The International Journal of Women's Dermatology is now listed on PubMed Central.

Murrell DF, Grant-Kels J.

Int J Womens Dermatol. 2017 Jul 8;3(3):126. doi: 10.1016/j.ijwd.2017.06.003. eCollection 2017 Sep. No abstract available.

48.

Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Amber KT, Murrell DF, Schmidt E, Joly P, Borradori L.

Clin Rev Allergy Immunol. 2018 Feb;54(1):26-51. doi: 10.1007/s12016-017-8633-4. Review.

PMID:
28779299
49.

The Experience of Families With Children With Spinal Muscular Atrophy Type I Across Health Care Systems.

Murrell DV, Lotze TE, Farber HJ, Crawford CA, Wiemann CM.

J Child Neurol. 2017 Oct;32(11):917-923. doi: 10.1177/0883073817716853. Epub 2017 Jul 3.

PMID:
28671037
50.

Quality of Life in Greek Patients with Autoimmune Bullous Diseases Assessed with ABQOL and TABQOL Indexes.

Patsatsi A, Kokolios M, Kyriakou A, Lamprou F, Stylianidou D, Tsapas A, Goulis DG, Murrell DF, Sotiriadis D.

Acta Derm Venereol. 2017 Oct 2;97(9):1145-1147. doi: 10.2340/00015555-2737.

Supplemental Content

Loading ...
Support Center